---
title: "Privia Health | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 632.63 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295090104.md"
datetime: "2026-08-06T10:25:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295090104.md)
  - [en](https://longbridge.com/en/news/295090104.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295090104.md)
generator: "portal-rs"
---

# Privia Health | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 632.63 M

Revenue: As of FY2026 Q2, the actual value is USD 632.63 M, beating the estimate of USD 600.76 M.

EPS: As of FY2026 Q2, the actual value is USD 0.07, beating the estimate of USD 0.0675.

EBIT: As of FY2026 Q2, the actual value is USD 15.08 M.

The provided reference, a Form 8-K filing, indicates that Privia Health Group, Inc. announced its financial results for the second quarter ended June 30, 2026. However, the detailed financial and operational metrics, including segment revenue, net income, gross margin, operating profit, operating costs, cash flow, or any company-specific indicators, are not included within the provided text of this Form 8-K. Additionally, no outlook or guidance content is present in the reference material.

### Related Stocks

- [PRVA.US](https://longbridge.com/en/quote/PRVA.US.md)

## Related News & Research

- [Privia Health files Form 3 for director Ernest Opella Finley](https://longbridge.com/en/news/297952652.md)
- [Barclays Reaffirms Their Hold Rating on Privia Health Group (PRVA)](https://longbridge.com/en/news/297307735.md)
- [Weekly Recap: 1.5M-share inducement grant and furnished Form 8-K PSU award](https://longbridge.com/en/news/298207980.md)
- [Equifax notifies availability of 8-K filing](https://longbridge.com/en/news/297785672.md)
- [REG - General Elec. - Doc re. GE Files 8-K](https://longbridge.com/en/news/298321667.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**